ONWRF
Price
$5.45
Change
+$0.21 (+4.01%)
Updated
Jul 2 closing price
Capitalization
236.27M
RGLS
Price
$8.16
Change
+$0.02 (+0.25%)
Updated
Jun 24 closing price
Capitalization
564.95M
40 days until earnings call
Interact to see
Advertisement

ONWRF vs RGLS

Header iconONWRF vs RGLS Comparison
Open Charts ONWRF vs RGLSBanner chart's image
Onward Med
Price$5.45
Change+$0.21 (+4.01%)
Volume$1.86K
Capitalization236.27M
Regulus Therapeutics
Price$8.16
Change+$0.02 (+0.25%)
Volume$9.34M
Capitalization564.95M
ONWRF vs RGLS Comparison Chart in %
Loading...
ONWRF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RGLS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ONWRF vs. RGLS commentary
Jul 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ONWRF is a Buy and RGLS is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 03, 2025
Stock price -- (ONWRF: $5.45 vs. RGLS: $8.16)
Brand notoriety: ONWRF and RGLS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ONWRF: 166% vs. RGLS: 255%
Market capitalization -- ONWRF: $236.27M vs. RGLS: $564.95M
ONWRF [@Biotechnology] is valued at $236.27M. RGLS’s [@Biotechnology] market capitalization is $564.95M. The market cap for tickers in the [@Biotechnology] industry ranges from $306.14B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ONWRF’s FA Score shows that 0 FA rating(s) are green whileRGLS’s FA Score has 0 green FA rating(s).

  • ONWRF’s FA Score: 0 green, 5 red.
  • RGLS’s FA Score: 0 green, 5 red.
According to our system of comparison, RGLS is a better buy in the long-term than ONWRF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ONWRF’s TA Score shows that 5 TA indicator(s) are bullish while RGLS’s TA Score has 2 bullish TA indicator(s).

  • ONWRF’s TA Score: 5 bullish, 4 bearish.
  • RGLS’s TA Score: 2 bullish, 5 bearish.
According to our system of comparison, ONWRF is a better buy in the short-term than RGLS.

Price Growth

ONWRF (@Biotechnology) experienced а +19.81% price change this week, while RGLS (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.15%. For the same industry, the average monthly price growth was +33.42%, and the average quarterly price growth was +4.05%.

Reported Earning Dates

RGLS is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+7.15% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RGLS($565M) has a higher market cap than ONWRF($236M). RGLS YTD gains are higher at: 416.456 vs. ONWRF (-9.147).
ONWRFRGLSONWRF / RGLS
Capitalization236M565M42%
EBITDAN/A-47.08M-
Gain YTD-9.147416.456-2%
P/E RatioN/AN/A-
RevenueN/A0-
Total CashN/A65.4M-
Total DebtN/A1.4M-
FUNDAMENTALS RATINGS
RGLS: Fundamental Ratings
RGLS
OUTLOOK RATING
1..100
29
VALUATION
overvalued / fair valued / undervalued
1..100
60
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
34
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ONWRFRGLS
RSI
ODDS (%)
Bearish Trend 2 days ago
71%
Bearish Trend 2 days ago
88%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
60%
Bearish Trend 2 days ago
84%
Momentum
ODDS (%)
Bullish Trend 2 days ago
31%
Bearish Trend 2 days ago
86%
MACD
ODDS (%)
Bullish Trend 2 days ago
31%
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
32%
Bullish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
36%
Bullish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 2 days ago
50%
Bullish Trend 10 days ago
84%
Declines
ODDS (%)
N/A
Bearish Trend 22 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
50%
Bearish Trend 2 days ago
86%
Aroon
ODDS (%)
Bearish Trend 2 days ago
60%
Bullish Trend 2 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
ONWRF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RGLS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MPGFX173.06N/A
N/A
Mairs & Power Growth
ITGSX92.77N/A
N/A
VY® T. Rowe Price Growth Equity S
ICRPX25.85N/A
N/A
VY® CBRE Real Estate A
SIVIX16.90N/A
N/A
State Street Instl Small-Cap Equity Inv
GGLCX12.43N/A
N/A
Gabelli International Small Cap C

ONWRF and

Correlation & Price change

A.I.dvisor indicates that over the last year, ONWRF has been loosely correlated with SHJBF. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if ONWRF jumps, then SHJBF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ONWRF
1D Price
Change %
ONWRF100%
+4.03%
SHJBF - ONWRF
42%
Loosely correlated
N/A
CNTA - ONWRF
24%
Poorly correlated
+4.33%
UCBJF - ONWRF
23%
Poorly correlated
N/A
INO - ONWRF
22%
Poorly correlated
+4.90%
RGLS - ONWRF
21%
Poorly correlated
N/A
More

RGLS and

Correlation & Price change

A.I.dvisor indicates that over the last year, RGLS has been loosely correlated with ABEO. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if RGLS jumps, then ABEO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RGLS
1D Price
Change %
RGLS100%
N/A
ABEO - RGLS
44%
Loosely correlated
+5.39%
ATOS - RGLS
32%
Poorly correlated
+1.57%
NKTX - RGLS
31%
Poorly correlated
+1.46%
NAUT - RGLS
30%
Poorly correlated
+6.62%
SPRY - RGLS
28%
Poorly correlated
+4.10%
More